Evidence map›Paper›PMID 34503227›Full record

ReviewCancers2021

Global Trends in Cancer Nanotechnology: A Qualitative Scientific Mapping Using Content-Based and Bibliometric Features for Machine Learning Text Classification.

Nuwan Indika Millagaha Gedara, Xuan Xu, Robert DeLong, Santosh Aryal, Majid Jaberi-Douraki

Abstract readReview
In one paragraph

Review in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Nanotheranostics for gynecological cancers: a path forward for Africa.Medical oncology (Northwood, London, England) · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Predicting the Prognostic Value ofInternational journal of molecular sciences · 2022
    Article
  6. Article
  7. Editorial: Nano-Imaging in Translational Cancer Medicine.Frontiers in bioengineering and biotechnology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nuwan Indika Millagaha Gedara1DATA Consortium, Kansas State University Olathe, Olathe, KS 66061, USA.ORCID 0000-0002-9862-8685
Xuan Xu1DATA Consortium, Kansas State University Olathe, Olathe, KS 66061, USA.
Robert DeLongNanotechnology Innovation Center Kansas State, Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA.
Santosh AryalDepartment of Pharmaceutical Sciences and Health Outcomes, The Ben and Maytee Fisch College of Pharmacy, The University of Texas, Tyler, TX 75799, USA.
Majid Jaberi-Douraki1DATA Consortium, Kansas State University Olathe, Olathe, KS 66061, USA.ORCID 0000-0002-8505-6550

Funding

Re-engineering Tumor Cell-Derived Extracellular Vesicles with Exogenous Tags for Downstream AnalysisR15EB030815 · NIBIB · UNIVERSITY OF TEXAS TYLER · PI ARYAL, SANTOSH · 2020 to 2020
$427k
BioNexus KC KC217NIBIB NIH HHS R15 EB030815NIH HHS NIH-1R15EB030815-01
6 · The paper itself

Abstract

This study presents a new way to investigate comprehensive trends in cancer nanotechnology research in different countries, institutions, and journals providing critical insights to prevention, diagnosis, and therapy. This paper applied the qualitative method of bibliometric analysis on cancer nanotechnology using the PubMed database during the years 2000-2021. Inspired by hybrid medical models and content-based and bibliometric features for machine learning models, our results show cancer nanotechnology studies have expanded exponentially since 2010. The highest production of articles in cancer nanotechnology is mainly from US institutions, with several countries, notably the USA, China, the UK, India, and Iran as concentrated focal points as centers of cancer nanotechnology research, especially in the last five years. The analysis shows the greatest overlap between nanotechnology and DNA, RNA, iron oxide or mesoporous silica, breast cancer, and cancer diagnosis and cancer treatment. Moreover, more than 50% of the information related to the keywords, authors, institutions, journals, and countries are considerably investigated in the form of publications from the top 100 journals. This study has the potential to provide past and current lines of research that can unmask comprehensive trends in cancer nanotechnology, key research topics, or the most productive countries and authors in the field.

Indexed as

bibliometric measurescancermachine learning modelsnanomaterialsnanotechnologyvisualizing networks

Identifiers

PMID34503227
PMCPMC8431703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.